# OnCo record mipletamig (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mipletamig/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mipletamig" ;
  schema:name "Mipletamig"@en ;
  schema:alternateName "APVO436"@en ;
  schema:description "Mipletamig is a two-armed protein from Aptevo Therapeutics that holds a leukaemia cell and a T cell together so the T cell kills it. It is in an early trial with standard drugs in newly diagnosed acute myeloid leukaemia."@en ;
  schema:url <https://onco.cc/drugs/mipletamig/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1671584/000119312526361103/apvo-20260821.htm> ;
  onco:status "phase-1" ;
  onco:tag "pipeline" ;
  onco:modality "Bispecific T cell engager" ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/> ;
  onco:targets <https://onco.cc/targets/cd123/>, <https://onco.cc/targets/cd3/> ;
  onco:companies <https://onco.cc/companies/aptevo-therapeutics/> .
